OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL)

CUSIP: 67576A100

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
214,467,875
Total 13F shares
43,457,924
Share change
+3,000,321
Total reported value
$224,194,712
Put/Call ratio
84%
Price per share
$5.16
Number of holders
132
Value change
+$15,406,633
Number of buys
67
Number of sells
54

Quarterly Holders Quick Answers

What is CUSIP 67576A100?
CUSIP 67576A100 identifies OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q2 2023

As of 30 Jun 2023, OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by 132 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,457,924 shares. The largest 10 holders included SUMMER ROAD LLC, Opaleye Management Inc., BlackRock Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, DELTEC ASSET MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, and Nuveen Asset Management, LLC. This page lists 132 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.